SATELLOS BIOSCIENCE INC. (MSLE)
Satellos to Present Clinical Program Updates at ICNMD 2026
Satellos to Present Clinical Program Updates at ICNMD 2026
Agenus Announces Three-Year Survival Data from Phase 1b BOT+BAL Study in MSS Metastatic Colorectal Cancer to be Presented at ESMO GI 2026
Satellos to Present Clinical Program Updates at ICNMD 2026
Montauk Brewing Kicks Off Summer with 14th Anniversary Celebration, Limited Brew Barn Release and Beach Cleanup
Atea Pharmaceuticals Completes Patient Enrollment in Phase 3 C-FORWARD Trial Evaluating Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus
TD SYNNEX Reports Record Fiscal 2026 Second Quarter Results
Constellation Announces Extension of Expiration for Exchange Offers
Highlander Silver: Comprehensive Geophysical Program Maps Extensive System Concealed by Shallow Cover at Corani
Kymera Therapeutics Completes Enrollment in the Phase 2b BROADEN2 Trial of KT-621 in Atopic Dermatitis with Topline Data by Year-end 2026
Baker Hughes to Deliver Subsea Production Systems to Support Azule Energy’s Greater PAJ Development